Zobrazeno 1 - 10
of 142
pro vyhledávání: '"Gneo, L."'
Autor:
Nowak M; Department of Pathology and Molecular Pathology, Zurich, Zurich, Switzerland., Jabbar F; Cancer Genomics and Immunology Group, The Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK., Rodewald AK; Department of Pathology and Molecular Pathology, Zurich, Zurich, Switzerland., Gneo L; Cancer Genomics and Immunology Group, The Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK., Tomasevic T; Cancer Genomics and Immunology Group, The Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK., Harkin A; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson T; University of Southampton, Southampton, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, UK., Kerr R; Department of Oncology, University of Oxford, Oxford, UK., Oein K; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Sansom O; CRUK Beatson Institute of Cancer Research, Garscube Estate, Glasgow, UK., Kelly C; CRUK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Pezzella F; Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Kerr D; Nuffield Department of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Easton A; Department of Oncology, University of Oxford, Oxford, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK., Koelzer VH; Department of Pathology and Molecular Pathology, Zurich, Zurich, Switzerland; Department of Oncology, University of Oxford, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Church DN; Cancer Genomics and Immunology Group, The Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: dchurch@well.ox.ac.uk.
Publikováno v:
Cell reports. Medicine [Cell Rep Med] 2024 Sep 17; Vol. 5 (9), pp. 101727.
Autor:
Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RRAK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson T; Southampton University, Southampton, UK., Saunders MP; The Christie NHS Foundation Trust, Manchester, UK., Oien KA; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezzella F; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Browne M; Department of Oncology, University of Oxford, Oxford, UK., Glaire M; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Danielsen HE; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom O; School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Beatson Institute of Cancer Research, Glasgow, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kerr R; Department of Oncology, University of Oxford, Oxford, UK., Kerr D; Nuffield Division of Clinical and Laboratory Sciences, University of Oxford, Oxford, UK., Domingo E; Department of Oncology, University of Oxford, Oxford, UK; Cancer Research UK Scotland Centre, Glasgow and Edinburgh, UK., Church DN; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: david.church@well.ox.ac.uk., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Nuffield Department of Medicine, University of Oxford, Oxford, UK; Department of Oncology, University of Oxford, Oxford, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Feb; Vol. 25 (2), pp. 198-211.
Autor:
Frei AL; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Life Science Zurich Graduate School, PhD Program in Biomedicine, University of Zurich, Zurich, Switzerland., McGuigan A; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Sinha RR; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Glaire MA; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Jabbar F; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Gneo L; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Tomasevic T; Nuffield Department of Medicine, University of Oxford, Oxford, UK., Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Iveson TJ; Southampton University Hospital NHS Foundation Trust, Southampton, UK., Saunders M; The Christie NHS Foundation Trust, Manchester, UK., Oein K; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Maka N; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Pezella F; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK., Campo L; Department of Oncology, University of Oxford, Oxford, UK., Hay J; Glasgow Tissue Research Facility, University of Glasgow, Queen Elizabeth University Hospital, Glasgow, UK., Edwards J; School of Cancer Sciences, University of Glasgow, Glasgow, UK., Sansom OJ; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Cancer Research UK Scotland Centre, Edinburgh and Glasgow, UK., Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, UK., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Kildal W; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway., Kerr RS; Department of Oncology, University of Oxford, Oxford, UK., Kerr DJ; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK., Danielsen HE; Nuffield Division of Clinical Laboratory Sciences, University of Oxford, Oxford, UK.; Institute for Cancer Genetics and Informatics, Oslo University Hospital, Oslo, Norway.; Department of Informatics, University of Oslo, Oslo, Norway., Domingo E; Department of Oncology, University of Oxford, Oxford, UK.; Cancer Research UK Scotland Centre, Edinburgh and Glasgow, UK., Church DN; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Oxford NIHR Comprehensive Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.
Publikováno v:
The journal of pathology. Clinical research [J Pathol Clin Res] 2023 Nov; Vol. 9 (6), pp. 449-463. Date of Electronic Publication: 2023 Sep 11.
Autor:
Panetti S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., McJannett N; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Scarpa U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Smith C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Vardon A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Vettore L; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Whalley C; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Pan Y; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Várnai C; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Endou H; J-Pharma Co. Ltd, Yokohama, Kanagawa, Japan., Barlow J; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom., Tennant D; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Beggs A; Institute of Cancer and Genomics, University of Birmingham, Birmingham, United Kingdom., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
Blood advances [Blood Adv] 2023 May 09; Vol. 7 (9), pp. 1754-1761.
Autor:
Jabbar, F., Nowak, M., Rodewald, A-K., Gneo, L., Tomasevic, T., Harkin, A., Iveson, T.J., Saunders, M.P., Kerr, R., Oien, K.A., Maka, N., Hay, J., Edwards, J., Tomlinson, I., Sansom, O.J., Kelly, C., Easton, A., Domingo, E., Koelzer, V.H., Church, D.N.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S420-S420
Autor:
Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., De Simone D; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Bartnik A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Scarpa U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Panetti S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK., Potluri S; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK., Almowaled M; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, G12 0YN, UK., Barlow J; School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Jankevics A; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK., Lloyd G; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK., Southam A; School of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, B15 2TT, UK., Priestman DA; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK., Cheng P; Bio-Cancer Treatment International, Hong Kong Science Park, Hong Kong, China., Dunn W; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK.; Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, B15 2TT, UK., Platt F; Department of Pharmacology, University of Oxford, Oxford, OX1 3QT, UK., Endou H; J-Pharma Co. Ltd, Yokohama, Kanagawa, 230-0046, Japan., Craddock C; Institute of Cancer and Genomics, University of Birmingham, Birmingham, B15 2TT, UK., Keeshan K; Paul O'Gorman Leukaemia Research Centre, University of Glasgow, Glasgow, G12 0YN, UK., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK. francis.mussai@nhs.net., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, B15 2TT, UK.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Mar; Vol. 72 (3), pp. 543-560. Date of Electronic Publication: 2022 Aug 13.
Autor:
Senigagliesi B; Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy; Elettra-Sincrotrone Trieste S.C.p.A, Trieste, Italy. Electronic address: beatrice.senigagliesi@sissa.it., Samperi G; University of Parma, Parma, Italy. Electronic address: giuseppe.samperi@studenti.unipr.it., Cefarin N; Istituto Officina dei Materiali Consiglio Nazionale delle Ricerche, Trieste, Italy., Gneo L; University of Oxford, Oxford, UK. Electronic address: luciana.gneo@well.ox.ac.uk., Petrosino S; Telethon Institute of Genetics and Medicine, Naples, Italy. Electronic address: s.petrosino@tigem.it., Apollonio M; Department of Life Sciences, University of Trieste, Trieste, Italy., Caponnetto F; Pathology Department, University Hospital of Udine, Udine, Italy., Sgarra R; Department of Life Sciences, University of Trieste, Trieste, Italy. Electronic address: rsgarra@units.it., Collavin L; Department of Life Sciences, University of Trieste, Trieste, Italy. Electronic address: lcollavin@units.it., Cesselli D; Pathology Department, University Hospital of Udine, Udine, Italy; Department of Medicine, University of Udine, Udine, Italy. Electronic address: daniela.cesselli@uniud.it., Casalis L; Elettra-Sincrotrone Trieste S.C.p.A, Trieste, Italy. Electronic address: loredana.casalis@elettra.eu., Parisse P; Elettra-Sincrotrone Trieste S.C.p.A, Trieste, Italy; Istituto Officina dei Materiali Consiglio Nazionale delle Ricerche, Trieste, Italy. Electronic address: parisse@iom.cnr.it.
Publikováno v:
Nanomedicine : nanotechnology, biology, and medicine [Nanomedicine] 2022 Aug; Vol. 44, pp. 102582. Date of Electronic Publication: 2022 Jul 08.
Autor:
Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B152TT, UK., Rizkalla N; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B152TT, UK., Hejmadi R; Department of Pathology, University Hospital Birmingham, Birmingham, UK., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B152TT, UK., de Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B152TT, UK., Middleton G; Institute of Immunology and Immunotherapy, University of Birmingham, Edgbaston, Birmingham, B152TT, UK. G.Middleton@bham.ac.uk.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2022 Jul; Vol. 71 (7), pp. 1583-1596. Date of Electronic Publication: 2021 Nov 02.
Autor:
Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Mussai FJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
Frontiers in oncology [Front Oncol] 2021 May 20; Vol. 11, pp. 674720. Date of Electronic Publication: 2021 May 20 (Print Publication: 2021).